8-hydroxy-2-(di-n-propylamino)tetralin and sarizotan

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with sarizotan in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourdiol, N; Colpaert, F; Cuisiat, S; Lacharme, V; Newman-Tancredi, A; Vacher, B1
Bartoszyk, GD; Lorenc-Koci, E; Wardas, J; Wolfarth, S1

Other Studies

2 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and sarizotan

ArticleYear
Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities.
    Journal of medicinal chemistry, 2007, Feb-22, Volume: 50, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Benzofurans; Benzylamines; Dopamine D2 Receptor Antagonists; HeLa Cells; Humans; Radioligand Assay; Rats; Serotonin 5-HT1 Receptor Agonists; Signal Transduction; Stereoisomerism; Structure-Activity Relationship

2007
Contribution of the serotonin 5-HT1A receptor agonism of 8-OH-DPAT and EMD 128130 to the regulation of haloperidol-induced muscle rigidity in rats.
    Neuropharmacology, 2003, Volume: 45, Issue:8

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiparkinson Agents; Haloperidol; Male; Muscle Rigidity; Organic Chemicals; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists

2003